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Abstract 
 
 
Mutations were sought in Escherichia coli ribosomal RNA and ribosomal proteins 
that confer dependence to the antibiotic streptomycin, using both newly available 
as well as well-established genetic systems. I found that a classical ribosomal 
mutant, Sm-D3, was streptomycin dependent and had an additional mutation in 
another ribosomal component – protein L7/L12. The double mutant had an 8-fold 
lower streptomycin requirement as compared to Sm-D3 with a wild-type rplL. 
This supported a functional involvement of L7/L12 in the decoding center of the 
ribosome.  
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1. Introduction 
 
1.1 The ribosome 
 
The ribosome is a macromolecular complex on which the second step in gene 
expression takes place. Due to its central role in translation, it has been highly 
conserved in evolution.  
 
The prokaryotic ribosome (70S) is made of two subunits – referred to as large 
(50S) and small (30S) (Figure 1). In Escherichia coli the small subunit consists of 
21 proteins and a 16S rRNA molecule of 1542 nucleotides in length. The large 
subunit comprises of 31 proteins with two rRNA components – the 5S and 23S of 
120 and 1542 nucleotides in length respectively (Yusupov et al., 2001).  
 
 
 
Figure 1. Structure of E. coli 70S ribosome in complex with release factor 2 (in 
red) as determined by angular reconstitution to 14 Angstroms (from Klaholz et al., 
2003). 
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Despite its structural complexity, the core function of the ribosome is the 
synthesis of a protein chain by translation of messenger RNA using the charged 
adaptor RNA (Spirin and Gavrilova, 1969). In addition it has become increasingly 
clear that the RNA component of the ribosome is the most important catalytically, 
which means it is a ribozyme. In particular, the coupling of amino acids to form 
peptides (peptidyl-transferase reaction) is catalyzed by domain V of the 23S 
rRNA, known as the peptidyltransferase centre (Vester and Garrett, 1988; 
Douthwaite, 1992).  
 
 
 
 
 
 
Figure 2.  A graphical model of the peptidyl transferase centre of Haloarcula 
marismortui with substrates bound to the A (in purple) and P sites (in green). The 
functionally important nucleotide of 23S rRNA A2486 (E. coli numbering A2451) 
(in orange) as well as possible hydrogen bonds (broken lines) are indicated (from 
Moore and Steitz, 2003). 
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The ribosome can be divided into functional domains. These include binding sites 
for mRNA, tRNA, as well as protein factors. The decoding function of the 
ribosome – mRNA binding and tRNA selection, is primarily governed by the 
small subunit. This site on the prokaryotic ribosome is the focus of this study. 
Hence, a more detailed discussion follows on the specifics of this aspect of the 
translation process. 
 
 
1.2 16S rRNA 
 
In all organisms, translation initiation sets the reading frame of translation. The 
start codon of messenger RNA specifically interacts with the methionyl-tRNA in 
the peptidyl donor centre of the small subunit. In addition, in most eubacteria, a 
second specificity determinant is present. This is a polypurine tract 5 of the start 
codon on mRNA. This sequence interacts complementarily with a 3 end of 16S 
rRNA known as the Shine-Dalgarno sequence (Ganoza et al, 2002). Additionally, 
other conserved regions on the 16S rRNA, such as nucleotides 1471-1480 and 
458-466 have been proposed to bind sequences 5 or 3 of mRNA start codon 
(Sprengart et al, 1996). 
 
The 16S rRNA contains a conserved sequence located in the 1400-1500 region. A 
number of experimental observations have demonstrated that the “heart” of the 
decoding centre is encompassed by the nucleotides C1399-C1409 and G1492-
G1504. Evidently that the major groove of the 1400-1500 region houses the tRNA 
and mRNA of the translation complex (Easterwood and Harvey, 1995). 
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Figure 3.  A portion of E. coli 16S rRNA showing secondary structure and the 
functionally important 1400-1500 region as well as the 530 loop (from Brinkier-
Gringas et al., 1995). 
 
 
The majority of antibiotics that perturb translational accuracy interact with the 
small subunit, mostly with sites on 16S rRNA. In many cases, single mutations in 
RNA confer resistance to these antibiotics relating to a fact that they interact 
directly with 16S rRNA. Additionally, chemical probing experiments have 
demonstrated that hyper- or hypo-accurate mutations in ribosomal proteins S12 
and S4 respectively affect tertiary conformation of 16S rRNA, indicating that 
these phenotypes could partly be due to altered RNA structure (Powers and 
Noller, 1994).  
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Biochemical studies also show that selected nucleotides on 16S and 23S rRNA 
interact, either directly or indirectly, with tRNA in the A, P and E sites on the 
ribosome. tRNA bound in the A site specifically protects nucleotides in 16S 
rRNA from chemical probes. These sites are clustered in the 1400-1500 region as 
well as the 530 stem-loop structure (Moazed and Noller, 1990). The 1400-1500 
region is located in the small ribosomal subunit cleft, thought to be involved in 
codon-anticodon interaction (Scheinman et al, 1992). On the other hand, the 530 
stem-loop structure is located near ribosomal proteins S4, S5 and S12 (Oakes and 
Lake, 1990).  
 
 
1.3 Streptomycin 
 
Streptomycin belongs to the aminoglycosidic group of drugs. It is a carbohydrate 
with strong basic properties which acts by specifically inhibiting the decoding 
apparatus of the 30S subunit.  At low concentrations this drug causes translational 
errors – misreading of the template mRNA. This is illustrated in the fact that there 
is stimulation of binding of aminoacyl-tRNA’s that do not correspond to codons 
on the template mRNA. For example, polyU mRNA normally binds phenylalanyl-
tRNA, and only very weakly binds isoleucyl-tRNA. In the presence of 
streptomycin, the affinity for isoleucyl-tRNA is increased, along with leucyl-
tRNA and seryl-tRNA (Spirin and Gavrilova, 1969). At higher concentration, 
streptomycin completely abolishes protein synthesis resulting in cell death 
without lysis. 
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Figure 4.  Molecular structure of streptomycin (from Spirin and Gavrilova, 1969). 
 
 
1.4 Interaction of 16S rRNA, ribosomal protein S12 and streptomycin 
 
Classically, mutations in the ribosomal protein S12 confer resistance and/ or 
dependence to streptomycin. Streptomycin resistance mutations in S12 are 
clustered in two regions: T6 and T15. Interestingly, streptomycin dependent 
mutations are found in the same regions of S12 as resistance mutations. This 
points to these two small regions as functionally important (Wittmann and 
Wittmann-Leibold, 1974).  
 
The presence of multiple ribosomal RNA operons in most eubacteria (there are 
seven in E. coli) hampers the mutational analysis of structure-function relations 
within rRNA. However, the existence of a limited number of rRNA operons in 
Mycobacterium smegmatis, as well as the engineered Escherichia coli strains with 
single rRNA operons made possible the detection of streptomycin resistance and 
dependence mutations within 16S rRNA (Springer et al., 2001). Most 
streptomycin resistance mutations in E. coli have been mapped to the 912-915 
region on 16S rRNA. This region positioned within the 30S decoding centre is 
widely regarded as the streptomycin binding site, however, other regions within 
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this molecule have also been implicated, such as position 13 as well as the 530 
stem-loop structure. Interestingly, a streptomycin dependence mutation has been 
isolated within the 530 stem-loop structure in M. smegmatis (Honore et al., 1995). 
Thus various sites on 16S rRNA are involved in streptomycin binding, but do not 
necessarily interact with it directly, instead control conformational changes 
associated with its binding (Brakier-Gingras et al., 1995).  
 
 
 
Figure 5.  A close up of the induced fit model of 30S subunit showing the 
decoding centre and binding sites of streptomycin and paromomycin. Relevant 
functional elements are indicated (from Ogle et al., 2003).  
 
 
1.5 Ribosomal protein L7/L12 
 
L7/L12 is one of the more extensively studied proteins in the ribosome. This is in 
part due to its central locality within a highly flexible protuberance on the 
ribosome – the stalk (Gudkov, 1997). The various conformations of the stalk are 
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reflective of its functional roles essential for binding of tRNA as well as 
translocation of peptidyl-tRNA from the A-site to P-site (Bocharov et al., 2004). 
The monomer of L7/L12 is an acidic protein of 12 kDa. L7 is the N-terminal 
acetylated form of L12. L7/L12 is the only ribosomal protein present in more than 
one copy on the ribosome. Each monomer is present in four copies, as two dimers. 
The two dimer complex is in turn associated with other ribosomal parts through 
an intimate interaction with protein L10 on the large 50S subunit (Ostberberg et 
al., 1977).  The pentameric structure comprising L10 and L7/L12 tetramer are 
collectively known, in E. coli, as the L8 complex (Petterson et al., 1976). 
 
 
1.6 Functional domains of L7/L12 
 
L12 can be divided into at least three functional domains. The C-terminal domain 
(CTD) is primarily responsible for the GTPase activity and association with 
translation factors (Kischa et al., 1971). An N-terminal domain (NTD) is involved 
in dimerization as well as L10 binding (Gudkov et al., 1995). Finally, the 
intervening hinge region facilitates the independent movement of the terminal 
domains. The overall body of evidence suggests that the hinge region confers a 
great deal of flexibility. In addition, L7/L12 can assume at least two different 
conformations, and its flexible nature is largely responsible for its function 
(Hamman et al., 1996a,b).   
 
 
1.7 Map location of rplL and the chromosome of rifd18 transducing phage 
 
Much work has been done to elucidate the genes involved in transcriptional and 
translational components of E. coli. In addition, the mapping of such genes has 
been well documented and refined, firstly through classical genetic experiments as 
well as the more recent sequencing of the E. coli genome. The defective 
transducing phage rifd18 has been particularly instrumental in the studies of the 
gene cluster around the 88 minutes on the chromosome. This cluster includes 
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several components of translational machinery – 16S, 23S and 5S rRNA, the 
spacer tRNA (including tgtB, thrU, tyrU, glyT and thrT), EF-Tu, as well as the 
50S ribosomal proteins L11, L1, L10 and L7/L12. In addition, the genes coding 
for two RNA polymerase subunits  and ’, are also present in this cluster 
(Lindahl et al., 1977). 
 
 
 
 
 
Figure 6. Genetic map of a portion of the rifd18 chromosome. Selected 
restriction endonuclease recognition sites are indicated with arrows. Distances 
between these are in %- units (from Lindahl et al., 1977). 
 
 
1.8 Interaction of L7/L12 with elongation factors and S12 
 
It has now been well established that L7/L12 dimer is an essential feature in the 
ribosome involved in elongation factor binding and translocation events 
(Bocharov et al., 2004). There is sufficient evidence that the L7/L12 stalk is a 
movable ribosome module taking direct part in EF-Tu and EF-G associated 
events, and in particular, EF-G mediated translocation. In addition, it has been 
found that changes induced in the L7/L12 stalk, following EF-GGTP binding and 
subsequent GTP cleavage, alter the conformations of both the large and small 
ribosomal subunits (Spirin, 2002). This is suggestive that GTP cleavage affects 
long range conformational shifts within the ribosome during the translocation 
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process. Furthermore, it is clear that the large distance between the decoding site 
and GTP hydrolysis centre, points to a ribosomal conformational change as a 
means of coupling the two mechanisms. It seems that tRNA binding induces a 
domain closure in the 30S subunit, leading to subsequent tRNA selection. A 
number of mutations in S12 result in a “restrictive” phenotype – those that 
increase fidelity of protein synthesis. It has been observed that such mutations 
result in decreased rates of GTP hydrolysis by EF-Tu and enhanced accuracy 
during initial tRNA selection and subsequent proofreading (Bilgin et al., 1992). 
Since L7/L12 stalk is rather distant from the tRNA ternary complex, but is known 
to participate in EF-Tu GTPase activity, long range conformational changes, and 
possibly modulation of 23S rRNA conformations might provide a mechanism of 
action (Ogle et al., 2003). Finally, it appears that the L7/L12 stalk, S12 and the 
decoding centre of the ribosome are a linked functional unit, whose activity is not 
due to direct interactions, but alterations and modulation of various parts of the 
ribosome.  
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1.9 Aims of the study 
 
With the increasing need for a more detailed understanding of the functional 
interactions within important ribosomal regions, such as decoding and peptidyl 
transferase centers, and despite the current progress achieved with visualization 
techniques like crystallography and topography, the basic experimental approach 
of genetic characterization of antibiotic resistance mutations and relevant second 
site suppressors can yield a vast amount of insightful information.  
 
The aim of this study was the elucidation of some of the complex structure-
function relations within the 30S decoding centre, specifically involving the 
streptomycin binding site. To this extent, it is of interest to obtain mutations either 
in the 16S rRNA or ribosomal proteins (most likely S12) that confer streptomycin 
dependence in Escherichia coli. In order to obtain selectable mutations in 16S 
rRNA, an E. coli mutant was used in which all 7 chromosomal rRNA operons are 
deleted, and only one rRNA operon borne on a plasmid is present. Mutants were 
generated and screened using available techniques such as chemical mutagenesis 
and counter-selection.  
 
Streptomycin dependent mutants were then selected for streptomycin 
independence, thus allowing for second site suppressor mutations to be mapped 
and characterized using standard molecular techniques. In addition, suppressor 
mutations were sought at specific loci of interest, such as ribosomal protein 
L7/L12 and release factors.  
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2. Materials and Methods 
 
2.1. Escherichia coli strains 
 
The cultures listed in Table 1 were kept in 33% glycerol at -70°C for long term 
storage. For short term storage, streaked cultures on Luria Bertani (LA) agar were 
kept sealed in parafilm at 4°C. To obtain liquid cultures, single colonies of 
streaked cultures were used to inoculate 5ml of Luria Bertani (LB) broth, with 
subsequent incubation at 37°C on a rotary drum overnight. 
 
Table 1. Escherichia coli strains used in this study 
Strain Characteristics Source 
MM294-4 endA1, hsdr17, gyrA E. Dabbs 
NF910 rifd18, c1857s7 N. Fiil 
SQ170 7 rRNA, pKK3535, ptRNA67 C. Squires  
D7 7 rRNA, pTS1192U, ptRNA67 C. Squires  
YB101 Sp-S derivative of SQ170 This study 
YB102 Rif-R derivative of YB101 This study 
NF915 argH, his, leu, thi, thr, rel+ N. Fiil 
NF916 argH, his, leu, thi, thr, relA N. Fiil 
CAG18456 -, cysG0, zhf-3084::Tn10, rph-1 CGSC* 
KO1418 (codB-lacI)3,relA1?, 
bglA677::Tn10, spoT1?, 
bglB676::lacZ, bglGo-67, thi-1 
CGSC 
CAG18500 -, rph-1, thiC::Tn10 CGSC 
CAG18500 Rif-R Rif-R derivative of CAG18500 This study 
LL103 Spontaneous Sm independent 
revertant of Sm-D strain VT, rplL-
15 
E. Dabbs 
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LL103 Rif-R, Tet-R Rif-R derivative of LL103, 
thiC::Tn10 
This study 
XL1-Blue recA1, endA1, gyrA96, thi-1, 
hsdR17, supE44, relA1, lac [F’ 
proAB, lacIqZM15::Tn10 
Stratagene 
Sm-D2 Sm-D of NF915 This study 
Sm-D3 Sm-D of NF915 This study 
Sm-D4 Sm-D of NF915 This study 
Sm-D5 Sm-D of NF916 This study 
Sm-D6 Sm-D of NF916 This study 
Sm-D7 Sm-D of NF916 This study 
* E. coli Genetic Stock Centre. 
 
 
2.2 Phage 
P1 transducing phage lysates were stored at 4°C with 100µl of chloroform added 
to prevent bacterial contamination. In the case of lambda phages, suspensions 
were stored in SM buffer. 
 
Table 2. Phage used in this study 
Phage Characteristics Source 
P1 Mediates generalized trasnduction in E. coli C. Squires 
φ18456 CAG18456 derived P1 This study 
φ18500 CAG18500 derived P1 This study 
φ18500rifR CAG18500 Rif-R derived P1 This study 
φ1418 CAG1418 derived P1 This study 
φ103rifR LL103 Rif-R derived P1 This study 
cI857 Lambda c1857s7 Roche 
rifd18 NF910 derived  This study 
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2.3 Plasmids 
 
E. coli vectors were maintained in host strains at -70°C. Purified vectors were 
stored in sterile distilled water at -20°C. 
 
Table 3.  Plasmids used in this study 
Plasmid Size Characteristics Source 
pKK3535 11.864 kb E. coli low copy number 
vector derived from pBR322 
carrying rrnB operon, Amp-R 
J. Brosius 
pTS1192U ~12 kb Derived from pKK3535, Sp-R, 
Cm-R 
P. Sergiev 
pCY104 8.9 kb E. coli-Nocardia  shuttle 
vector 
G. Heiss 
pACYC184 4.245 kb Low copy number vector, Tet-
R, Cm-R 
Roche 
pUC18 2.686 kb E. coli high copy number  
vector, Amp-R 
Roche 
pUC18-L12 3.081 kb pUC18 construct with a cloned 
rplL ORF in BamHI and 
HindIII restriction sites 
This study 
pCMS71 4.2 kb Derivative of pCMS27 with 
lacZ cloning cassette 
C. M. 
Stenström 
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2.4 E. coli small-scale plasmid preparations 
 
E. coli cells were grown in 1ml of LB, supplemented with Sm and Amp to a final 
concentration of 200µg/ml, at 37°C on a shaker overnight. Cells were harvested 
by pelleting in a microfuge for 30 sec and resuspended in 80µl of solution 1. 
160µl of solution 2 was added, mixed by inversion, and left to stand at room 
temperature for 15 min. Thereafter, 120µl of pre-chilled solution 3 was added and 
mixed with vigorous shaking. This was left to stand in ice-water slurry for 5 min, 
and microfuged in the cold room for a further 5 min. The supernatant was 
decanted into a sterile Eppendorf tube and the pellet discarded. The supernatant 
was warmed up in a 37°C water bath and 220µl of isopropanol was added, mixed 
gently by inversion and microfuged for 5 min at room temperature. The 
supernatant was discarded and the Eppendorf tube blotted on a piece of paper 
towel. This was followed by the addition of 150µl of 96% ethanol, microfugation 
for 30 sec, supernatant again carefully discarded, and the Eppendorf tube blotted 
on a paper towel. The pellet was dried in a vacuum for 20 min, resuspended in 
150µl of sterile distilled water and stored at -20°C. 
 
 
2.5 DNA manipulations 
 
2.5.1 DNA digestion with restriction endonucleases 
 
Restriction enzymes were obtained from New England BioLabs, Amersham, 
Promega or Roche, and used according to the manufacturer’s specification. DNA 
to be digested was thawed from prior storage in a 37°C water bath. Aliquots of 
DNA (usually 13.5µl) were then mixed with a 1/9 volume from a 10 X stock 
solution of the appropriate restriction endonuclease buffer. This was mixed gently 
by tapping, to ensure uniform buffer distribution, and microfuged briefly. 0.3µl of 
the appropriate restriction endonuclease was then added, contents mixed and re-
spun. Digestion was carried out at 37°C, or at other temperatures as specified by 
the manufacturer, overnight, or for 4-5 hours if the restriction endonuclease 
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exhibited ‘star activity’. In the case of double digestions, a buffer was selected in 
which both the restriction endonucleases exhibited suitable activity. If ligations 
were performed following digestion, the restriction endonucleases and buffers 
were removed by phenol and chloroform extraction, DNA precipitated with 
sodium chloride (NaCl) and ethanol, dried in vacuum and resuspended in sterile 
distilled water. 
 
 
2.5.2 Agarose gel electrophoresis 
 
0.4% and 0.8% stock solutions of agarose were prepared in 0.5 X TBE. During 
preparation, the agarose stock solutions were autoclaved (121°C for 20 min), 
thereafter stored at room temperature. When the agarose solutions were required 
for use, the stock was melted in a microwave, 20ml of molten agarose was poured 
into a gel molder with fitted well-former at 4°C, and allowed to polymerize for 30 
min. The well-former was removed and the polymerized gel was placed into an 
electrophoresis unit. 200ml of electrophoresis buffer was then added such that the 
gel was submerged. Before loading, the DNA samples were mixed with 2µl 
tracking dye. Either λII or λIII molecular weight markers were also included in all 
gel electrophoresis runs. Electrophoresis was carried out at room temperature, and 
the parameters were set such that the voltage was 80-120V and the current 21-
30mA. The tracking dye was monitored until it reached the bottom of the gel. At 
this point, the gels were viewed and photographed with the use of Pharmacia 
Image VDS system. The sizes of DNA fragments on the gel were obtained either 
from visual estimation as compared to the standard molecular weight markers, or 
from a standard curve. 
 
 
2.5.3 Low-gelling agarose electrophoresis 
 
20ml of 1% low-gelling agarose was prepared in the same way as for the 
conventional agarose gel. The gel was run at 4°C in a pre-chilled electrophoresis 
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tank and a pre-chilled electrophoresis buffer at a voltage of 100-120V and a 
current of 21-25mA. The gel was visualized under UV light (366nm), DNA 
fragments of interest excised with a scalpel and placed in sterile Eppendorf tubes. 
Low-gelling agarose, containing the DNA fragments of interest were melted at 
60°C for 30 min and DNA was extracted as per section 2.5.4 and precipitated as 
per section 2.5.5. 
 
 
2.5.4 Phenol and chloroform DNA extraction 
 
TE buffer was added to the DNA sample, to a final volume of 300µl. One volume 
of TE-saturated phenol was added to the tube, mixed by inversion and microfuged 
at room temperature for 5 min. This was done to separate the organic and aqueous 
phases. The aqueous phase was then carefully pipetted into a sterile Eppendorf 
tube. In the case of DNA extraction from low gelling agarose, the addition of 1/3 
volume phenol and microfugation was repeated three times. Subsequently, 1/3 
volume of chloroform was added to the tube, mixed by inversion and microfuged 
for a further 30 sec. The top phase was then again pipetted into a sterile 
Eppendorf, and the DNA precipitated with NaCl and ethanol.  
 
 
2.5.5 NaCl and ethanol DNA precipitation 
 
Precipitation of DNA was achieved by addition of 1/10 volume of 1M NaCl and 
2.5 volumes of 96% ethanol. This was then microfuged for 20 min at 4°C. The 
supernatant was discarded, and the Eppendorf tube blotted on a paper towel to 
remove excess ethanol. Thereafter, the pellet was dried in vacuum for 20 min, and 
DNA resuspended in sterile distilled water. 
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2.6 Transformation of bacteria 
 
2.6.1 DNA transformation of E. coli  
 
 E. coli culture was grown in 5ml LB on a rotary shaker at 37°C overnight. 200µl 
of this pre-culture was then used to inoculate 20ml of pre-warmed LB containing 
0.5% of glucose in a 250ml flask. This was grown on a shaker at 37°C for 1.75 
hours or until OD(590) 0.2-0.4. Thereafter, the culture was rapidly chilled in ice-
water slurry for 5 min, and transferred to a pre-chilled JA-20 tube, which was 
centrifuged (5 min at 10000 rpm). The supernatant was discarded and the pellet 
resuspended in 10ml of pre-chilled calcium-chloride transformation buffer. This 
was left to stand in ice-water slurry for 15 min. Another centrifugation step 
followed (5 min at 10000 rpm), the supernatant discarded and the pellet again 
gently resuspended in 1.33ml of calcium-chloride transformation buffer. The 
preparation was then left to stand in ice-water slurry for 2-24 hours. DNA samples 
were then aliquoted into sterile Eppendorf tubes (usually 2µl of either large-scale 
or small-scale DNA preparations, and 20µl of ligation mixtures), and chilled in 
ice-water slurry for 10 min. 50µl competent cells were then added to each tube, 
tapped gently, and air was bubbled with the use of a P200 micropipette. This was 
left to stand in ice-water slurry for a further 15 min to allow for diffusion of DNA. 
Heat shocking was done in a pre-warmed 42°C water bath for 90 sec. 0.5ml of 
pre-warmed LB was then added to each tube, followed by incubation, with tops of 
Eppendorf tubes open, at 37°C for one hour to allow for phenotypic expression of 
the resistance genes. The cell suspensions were then spread on dried LA plates 
containing the appropriate antibiotic and incubated at 37°C overnight. 
 
 
2.6.2 Electroporation of E. coli 
 
1ml of stationary-phase culture, grown in LB supplemented with the appropriate 
antibiotic, was aliquoted into an Eppendorf tube and pelleted by microfuging for 
30 sec. The supernatant was discarded and the pellet resuspended in 1ml sterile 
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distilled water. Microfugation again followed for 30 sec and the supernatant 
discarded. The washing step was carried out three times to remove charged ions 
from solution. The cells were again resuspended in 1ml sterile distilled water. 
100µl of cells were then aliquoted into pre-chilled BioRad 0.2cm electroporation 
cuvettes. These were allowed to stand in ice-water slurry for 10 min to allow the 
cells to cool down. 10µl of DNA (from small-scale DNA preparation) was then 
added and allowed to stand for a further 10 min in ice-water slurry. The cells were 
electroporated using a BioRad GenePulser I with the following settings: voltage 
2.5kV, capacitance 25µF, resistance of 200Ω. Following electroporation, the cells 
were transferred to a sterile Eppendorf containing 1ml LB. These were incubated 
at 37°C for 1 hour to allow for phenotypic expression of the resistance gene, and 
then spread on LA plates supplemented with the appropriate antibiotic. The plates 
were then incubated at 37°C overnight. 
 
 
2.7 E.coli Transductions 
 
2.7.1 Preparation of P1 lysate 
 
Donor E. coli culture was grown overnight in 5ml LB on a rotary shaker 
overnight. 2.5ml of fresh pre-warmed LB was then aliquoted into 2 small (5ml) 
glass tubes each. 50µl of overnight donor culture, as well as 20µl of 1M CaCl2 
was added to each tube, then vortexed briefly to mix. To one of the tubes, 50µl of 
seeding lysate (phage titre = 1x109 pfu/ml) was added (the other tube served as a 
‘no phage’ control), vortexed briefly, and allowed to stand at room temperature 
for 30 min to permit phage attachment to cells. Subsequently, 2ml of warm (60°C) 
sloppy agar was added to each tube, rolled between the palms of the hands and 
spread on pre-chilled (4°C) LA + 10mM CaCl2 (LC) plates. These were allowed 
to set at room temperature, and incubated for 6-8 hours at 37°C. The two plates 
were then compared to detect a clearing in the agar as a result of cell lysis due to 
phage infection. The top layer (sloppy agar) of the phage containing plate was 
then transferred to a JA-20 centrifuge tube, and 100µl of chloroform added to lyse 
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the remaining cells. The tube was then vortexed briefly and centrifuged in a 
Beckman JA-20 rotor (10 min at 15000 rpm). Subsequently, the supernatant was 
collected in a sterile small 5ml bottle, another 100µl aliquot of chloroform added, 
and the bottle kept in ice for 3-4 days. Thereafter, the lysate was stored at 4°C.  
 
 
2.7.2 Lysate titre estimation of P1 phage  
 
Donor strains of E. coli were grown in 5ml LB on a rotary shaker at 37°C 
overnight. 2ml of LB was aliquoted into 5 small glass (5ml) tubes each. A dilution 
series of the prepared phage lysate was set up spanning the following range: 10-2; 
10-4; 10-6; 10-8. The fifth tube served as the ‘no phage’ control. To each tube, 50µl 
of cell culture, 20µl of 1M CaCl2, and 2ml of warm (60°C) sloppy agar was 
added, rolled between the palms of the hands, and plated on LC plates. The plates 
were then incubated at 37°C for 6-8 hours, until phage plaques became visible. 
The estimation of phage titre was done as follows: the plate with between 30 and 
300 plaques was counted, and the dilution taken into account. The phage titre was 
then: the number of plaques multiplied by the dilution factor divided by the 
volume plated (2ml).  
 
 
2.7.3 P1-mediated transduction 
 
100µl of stationary phase E. coli recipient culture grown in LC medium (LB + 
10mM CaCl2), and in the cases of Sm-D strains supplemented with Sm 100-
200µg/ml, was aliquoted into two Eppendorf tubes. The tubes were microfuged 
for 30 sec and the supernatant discarded. Cells were then resuspended in 1ml of 
fresh LC. To one of the tubes, 50-100µl of phage lysate was added, the other tube 
served as a ‘no phage’ control. Both tubes were mixed by inversion and allowed 
to stand for 30 min at 37°C for phage attachment to take place. Following this, the 
tubes were microfuged for 30 sec, the supernatant discarded, and the cells 
resuspended in 1ml of sterile distilled water. Microfugation again followed for 30 
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sec, and the cells resuspended in residual volume (~50µl) of water. The 
suspension was spread on LA plates supplemented with Tet to a final 
concentration of 10-40µg/ml, and in the cases of Sm-D strains, with Sm 100-
200µg/ml. The plates were incubated at 37°C overnight. 
 
 
2.8  Phage manipulation 
 
2.8.1 Small scale reparation of  phage  
 
Overnight culture of E. coli  lysogen was washed with water and 100µl was used 
to inoculate a 100ml flask containing 10ml LB medium. The culture was shaken 
at 30°C until an OD(590) 0.4-0.6 was reached. Culture was rapidly transferred to a 
44°C water bath for 10 min for heat induction of the lysogen. Thereafter, the 
culture incubated on a shaker at 37°C for 1-3 hours. 1ml aliquots were microfuged 
and resuspended in 0.5ml LM (LB + 10mM MgCl2) medium. 20µl of chloroform 
was then added and microfuged for 5 sec to lyse the cells. Lysates were stored at 
4°C. 
 
 
2.8.2 Large scale preparation of  phage 
 
E. coli  lysogen starter culture was in 5ml LB on rotary shaker at 25°C overnight. 
2ml of culture was diluted in 200ml LB in 2L flask and shaken at 30°C until an 
OD(590) of between 0.4-0.6 was reached. The flask was then rapidly transferred to 
a 44°C water bath and incubated with agitation for 20 min.   This was followed by 
incubation at 37°C on a shaker for a further 4 hours. The cells were pelleted in 
Beckman JA-10 rotor (20 min at 6000 rpm) and resuspended in 10ml of SM 
buffer. 1ml of chloroform was then added to the suspension, and incubated on a 
shaker at 37°C for 10 min. Thereafter, 20µl of DNase I (1mg/ml) was added to the 
suspension and incubated for a further 10 min on a 37°C shaker. The lysates were 
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stored overnight at 4°C. An additional DNase treatment was done, before the 
lysate was centrifuged in Beckman JA-10 rotor (15 min at 10000 rpm). The 
supernatant was transferred to a clean bottle using a Pasteur pipette avoiding the 
bottom chloroform phase. 50% w/v of CsCl was added to the lysate and dissolved. 
A CsCl block gradient in Beckmann Quick seal tubes was prepared as follows: 
3.5ml of the lysate suspension in CsCl was added to the tube using a long-neck 
Pasteur pipette. This was followed by 0.5ml each of CsCl solutions in SM buffer 
of specific densities 1.45, 1.5 and 1.7 g/ml, in such a way that each solution was 
added to the bottom of the tubes sequentially. Tubes were balanced and sealed. 
Centrifugation was carried out in a Beckmann VTi65.2 rotor (1 hour at 25000 
rpm). The distinct blue band containing phage particles was extracted from the 
tube using a hypodermic needle. 
 
 
2.8.3 DNA extraction from  phage 
 
The CsCl fraction containing  phage was dialyzed twice against 250ml of  
dialysis buffer.  The dialyzed suspension was then transferred to a sterile 
Eppendorf tube. 0.5M EDTA (pH 8.0) was added to a final concentration of 
20mM. This was followed by the addition of a small amount (on a tip of a 
toothpick) of proteinase K and 10% v/w solution of SDS to a final concentration 
of 0.5%. The tube was incubated at 56°C for 1 hour.  phage DNA was then 
extracted using the standard phenol-chloroform DNA extraction protocol, and 
precipitated with NaCl and ethanol. 
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2.9 Mutagenesis of E. coli 
 
2.9.1 EMS mutagenesis of E. coli 
 
100µl of overnight E .coli culture was used to inoculate 10ml of fresh LB in a 
100ml flask. This was grown on a shaker at 37°C for 1-3 hours, to mid-
logarithmic phase. 1ml of culture was then aliquoted into a sterile Eppendorf tube, 
microfuged for 30 sec, supernatant discarded, and the cells resuspended in 1ml of 
phosphate buffer (pH = 7.0). Methanesulphonic acid ethyl ester (EMS) was added 
to the tube to a concentration of 1-2% (v/v). The tubes were incubated for 1-2 
hours at 37°C. Thereafter, the tubes were microfuged for 30 sec, the supernatant 
discarded, and the cells resuspended in 1ml of phosphate buffer. The washing step 
was done twice. Cells were resuspended in residual volume of phosphate buffer, 
and a dilution series was plated on LA plates under-laid with Sm to a final 
concentration of 200µg/ml. 
 
 
2.9.2 NTG mutagenesis of E. coli 
 
A solid phase culture of E. coli grown on an LA plate was scraped using a sterile 
toothpick and resuspended in 1ml Tris-maleate buffer (pH 4.8). NTG solution was 
prepared by dissolving 1.5mg of NTG powder in 1ml Tris-maleate buffer by 
heating in microwave oven for 4-5 sec.  100µl of this solution was added to the 
resuspended cells and incubated at 37°C for 10-15 min. Cells were microfuged 
and pallet washed twice with phosphate buffer (pH7.0) to inactivate the NTG. The 
pellet was resuspended in 10ml of LB, and in the case of SQ170, supplemented 
with Amp to a final concentration of 100µg/ml. 
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2.10 Counter-selection 
 
100µl of NTG mutagenized overnight culture was aliquoted into an Eppendorf 
tube.  This was microfuged for 30 sec, the supernatant discarded, and the cells 
resuspended in 1ml of sterile distilled water. The washing step was done twice to 
remove residual antibiotic. Cells were resuspended in residual volume of water 
and added to 10ml of LB in a 100ml flask, which was incubated on a shaker at 
37°C for 2 hours. Subsequently, Amp or Nal was added to a final concentration of 
50µg/ml and 100µg/ml respectively, and incubated for 1-2 hours. 100µl of cells 
were then aliquoted into an Eppendorf, microfuged for 30 sec, supernatant 
discarded, cells resuspended in 1ml of sterile distilled water. Washing step was 
repeated twice. The cells were used as inocula for 10ml of LB supplemented with 
Amp (in the case of SQ170) to a final concentration of 200µg/ml, and incubated 
overnight at 37°C. The counter selection procedure was again repeated at least 
twice.  Washed cells were serially diluted 10-fold, 100-fold and 1000-fold and 
plated on LA plates supplemented with Amp to a final concentration of 200µg/ml. 
Plates were incubated at 37°C. Colonies thus obtained, were patched onto LA 
supplemented with Amp to a final concentration of 200µg/ml and incubated at 
37°C. 
 
 
2.11 Determination of reversion frequency of Sm-D mutants 
 
5ml of overnight LB culture in 100ml flasks, supplemented with Sm to a final 
concentration 200µg/ml, were grown overnight at 37°C on a shaker. 1ml of 
culture was pelleted and washed in water twice. 100µl aliquots were spread onto 
LA plates and incubated for 1-4 days at 37°C. The reversion frequency was then 
calculated based on the number of colonies present on LA plates and the number 
of CFU/ml for each mutant in the original culture. 
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2.12 Plate patching technique 
 
This technique was employed to detect particular phenotypes of E. coli under 
varying conditions antibiotic concentration. Individual colonies of E. coli were 
picked up using sterile toothpicks and streaked on LA and LA plates 
supplemented with an antibiotic. The streaking was done in a manner such that 
each individual colony could be identified on different LA plates. To achieve this, 
a numbered pattern was placed under each LA plate, and a streak was made on a 
particular corresponding number. The LA plates were then incubated for various 
durations of time (1-2 days) at 37°C. The phenotype was assessed based on the 
ability of the streaked cells to form confluent growth. 
 
 
2.13 Spot tests 
 
Spot tests were performed to determine various mutant phenotypes of E. coli 
under varying conditions of temperature and antibiotic presence or concentration. 
For this purpose, a replicator was used. Each well was filled with ~200µl of sterile 
distilled water. Individual colonies were then inoculated into each well, and a 
flame-sterilized replicator was used to replicate the bacterial suspensions onto 
appropriate plates. These were incubated under varying conditions, for varying 
durations of time (1-2 days). Phenotypes were assessed based on the ability of 
cells to form confluent growth. 
 
 
2.14 -Galactosidase assay 
 
A modified version of the -galactosidase assay by Miller J. H., was used. Host E. 
coli strains were transformed with the plasmid carrying the reporter lacZ gene. 
These were grown to stationary phase in LB supplemented with Sm 200µg/ml in 
the case of Sm-D mutants, and Amp 200µg/ml. Cultures were used to inoculate 
3ml of the same medium at a 100 X dilution and grown to an exponentially 
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growing phase at an OD(590nm) of 0.4-0.5 without IPTG induction. Thereafter, all 
the proceeding steps were carried out on ice. Cells were harvested by diluting 
100µl of culture in 900µl of Z-buffer with previously added chloroform (3 drops) 
and SDS (1 drop). Lysis of cells was done with vigorous vortexing for 15 sec. A 
chromogenic substrate o-nitrophenyl--galactosidase (ONPG) was used to assay 
-galactosidase activity. All measurements were done using an iEMS Multiscan 
Microplate Photometer (Labsystems). 
 
 
2.15 Polymerase Chain Reaction (PCR) 
 
PCR was done in a Perkin Elmer Geneamp 2400 thermal cycler. Taq polymerase 
was used as a master-mix reaction with dNTP’s and a standardized concentration 
of MgCl2 from Fermentas. The following thermal parameters were used based on 
primer melting temperature (Tm): an initial denaturation step for 5 min at 94ºC; a 
cycle denaturation step for 1 min at 94ºC; an annealing step for 45 sec at 53ºC; 
and an extension step for 45 sec at 72ºC. This cycle was repeated 35 times. A final 
extension step was done for 7 min at 72ºC. Colony PCR was preformed to amplify 
wild-type chromosomal rplL. A toothpick was used to pick off a single colony 
from an LA plate and used to inoculate the PCR reaction mixture directly. 
Following PCR, a small aliquot was used to detect the presence of the desired 
product on a 1% agarose gel. 
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3. Results 
 
3.1 Selection of streptomycin dependent (Sm-D) mutants of strain SQ170 
 
E. coli strain SQ170 is deficient in all the seven rRNA operons on the 
chromosome and carries a single copy of the rrnB operon (containing 16S, 23S 
and 5S rRNA) on a plasmid pKK3535. Additionally, it has a second compatible 
plasmid ptRNA67 containing tRNA genes as well as a Sp-R determinant. This 
plasmid is essential since SQ170 lacks a number of chromosomally encoded 
tRNA genes that were deleted along with rRNA operons. It became obvious that 
prior to any mutagenesis and subsequent selection of Sm-D mutants of SQ170, the 
Sp-R determinant in this strain had to be removed. This is because both Sm and 
Sp are aminoglycosidic antibiotics, and potential resistance had to be avoided.   
 
 
3.2 Selection of spectinomycin sensitive (Sp-S) SQ170 mutants 
 
Following NTG mutagenesis and three consecutive rounds of counter-selection 
using Nal as a bactericidal agent, a dilution series (10-1; 10-2; 10-3) was plated on 
Amp containing LA plates. Selected colonies were patched on LA-Amp only and 
LA-Amp/Sp plates. Of the 111 colonies tested, 25 showed a Sp-S phenotype 
(these colonies failed to grow on Sp supplemented plates). It was necessary to 
identify Sp-S clones that showed no resistance to Sm. 18 Sp-S colonies were 
selected to perform a spot test to determine Sm-R phenotype on increasing 
concentrations of Sm containing LA plates. 
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Clones 2, 10 and 18 were ideal candidates for further work since these showed the 
‘cleanest’ Sm-S phenotype and failed to produce any spontaneous resistance 
mutants.  These clones, along with clones 2, 4, 6 and 12 were used to test for 
spontaneous resistance genesis by plating 100l of washed stationary phase 
culture on Sm supplemented LA plates. All clones except 10 produced a small 
number of spontaneous resistance mutants. Thus it was decided that clone 10 
would be most useful for generating Sm-D mutants. This clone was named 
YB101. 
 
 
3.3 Selection of YB101 Sm-D mutants 
 
YB101 was subjected to EMS mutagenesis and plated on LA plates under-laid 
with Sm. Selected colonies were patched on LA with Amp only and LA 
supplemented with Amp/Sm plates to detect Sm-D mutants. Out of 104 colonies 
screened, 101 exhibited an Sm-D phenotype (~97%), the rest were Sm-R clones. 
19 Sm-D clones, as well as 1 resistant clone  were selected and used in a spot-test 
to determine Sm-D phenotype. 
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Table 4. Spot-test to determine Sm-D phenotype of selected YB101 derived 
mutants 
LA-N supplemented with antibiotic (g/ml): YB101 
mutant Sm0 Sm5 Sm10 Sm20 Sm40 Sm80 Sm160 
1* +++ +++ +++ +++ +++ +++ +++ 
2 - - - - -(2°) ++ +++ 
3 - --+ -(2°) -++(2°) ++ +++ +++ 
4 - - - - -+(2°) +++ +++ 
5 - - - - -+(2°) +++ +++ 
6 - - - -(2°) -+(2°) +++ +++ 
7 - --+ --+ -+(2°) -+(2°) +++ +++ 
8 --+ --+(2°) -+(2°) + ++ +++ +++ 
9 - -(2°) -(2°) -+(2°) + +++ +++ 
10 - - - - -+ ++ +++ 
11 --+ --+ -+(2°) -+ + ++ +++ 
12 --+ -+(2°) -+(2°) -+(2°) +(2°) +++ +++ 
13#        
14 - - - - - - +++ 
15 --+ --+ --+(2°) --+(2°) + ++ +++ 
16 --+ --+ -+(2°) -+(2°)
 
+ ++ +++ 
17 --+ --+(2°) --+(2°) -+(2°) + ++ +++ 
18 -+ -+ + + + ++ +++ 
19 -+ -+(2°) + + + ++ +++ 
20 - -(2°) -+(2°) +(2°) + ++ +++ 
 
Bacterial growth is indicated by (+) or (-), where (+++) is maximal confluent 
growth (++) is intermediate confluent growth, (+) single colonies (-+) is sparse 
single colonies, (--+) is very sparse growth, while (-) is complete absence of 
growth. (2°) indicates the presence of secondary colonies. 
*  Sm-R control. 
#  mutant failed to produce any growth at 37°C. 
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It was desirable to select Sm-D mutants that showed varied requirements for 
streptomycin: YB101 mutants 2, 4, 6, 9, 10, 14, 16 and 20 were selected for 
further work.  
 
Of interest was to obtain YB101 mutants that carried Sm-D mutations within the 
rRNA operon (i.e. plasmid-borne).   To test whether any of the YB101 Sm-D 
mutants carried such mutations, a simple strategy was employed. This involved 
transformation of YB101 with plasmid DNA derived from all selected Sm-D 
mutants. Selection of transformed cells was done on LA-N supplemented with 
Amp only and Amp/Sm.  
 
Transformation of YB101 failed to produce a significant number of colonies with 
varying amounts of competent cells and plasmid DNA. It appeared that the 
recipient YB101 strain was competent as indicated by presence of transformants 
with the positive control pCY104 plasmid that conferred resistance to Cm (results 
not shown). However, the presence of large colonies on a number of Sm 
supplemented plates, including the no DNA control plate suggested that these 
could be spontaneous Sm-R clones and not genuine transformants. This was 
confirmed by performing a patch on LA-N supplemented with Amp only and 
Amp/Sm. It became obvious that there was a general problem with 
transformability of the Sm-D phenotype from candidate Sm-D mutants into 
recipient YB101. In order to overcome this, a number of variables were changed. 
These included: 
1. In order to minimize contamination during transformation, YB101 was 
made resistant to Rif 200g/ml – new clone called YB102. 
2. Compared transformation using electroporation and CaCl2 method. 
Calibrated with E. coli MM294-4 and pUC18. It was concluded that 
transformation efficiency using electroporation was 4 times more 
efficient.  
3. To increase the purity and quantity of plasmid DNA, used an Amersham 
GFX™ Micro Plasmid Kit to prepare DNA from selected YB101 Sm-D 
mutants 2, 4, 6, 9 as well as DNA from a pool of all Sm-D clones. 
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Table 5.  Transformation of YB102 with plasmid DNA from an Amersham 
GFX™ Micro Plasmid Kit using optimized electroporation conditions 
YB102 transformed with 
DNA: 
Number of colonies on LA-N   
Rif200/Amp200 (g/ml): 
None 0 
pCY104# 37 
YB101(2) 0 
YB101(4) 0 
YB101(6) 3 
YB101(9) 8 
YB101(Pool) 14 
 
# in the case of pCY104 transformation, selection was on LA-N supplemented 
with Cm100/ Amp 200 (g/ml). 
 
Despite the recurrent problem of low transformation efficiency, colonies were 
assayed for Sm-D using a spot test (not shown). The results of the spot test 
indicated Sm-D transformability was not achieved in any case. Furthermore, a 
slow growing Sm-R phenotype was observed for all transformants throughout the 
Sm concentration range. On the basis of this, it was hypothesized that in all 
selected Sm-D mutants of YB101, there were at least two Sm-D conferring 
mutations. One plasmid-borne mutation that imparted an Sm-R phenotype in one 
of the rRNA genes, and a second genomic dependence imparting mutation 
(possibly in S12). Alternatively, a mixed population of ribosomes in the recipient 
YB101 strain contributed to the observed phenotype. In this case, a merodiploid 
condition was present, whereby more than one rRNA plasmid borne operon was 
actively expressed. To resolve this matter, a marker rescue experiment was 
performed. Sm-D mutants YB101(6) and YB101(9) were transduced with P1 
phage derived from strain CAG18456 that carries a Tn10 near rpsL.  
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Table 6. Transduction of YB101(6) and YB101(9) with 18456 
Number of colonies on LA-N supplemented with 
antibiotic (g/ml): 
Sm-D mutant 
Tet50 Tet50/Sm200 
YB101(6) -  0 0 
YB101(6) +  0 178 
YB101(9) -  0 0 
YB101(9) +  0 234 
 
 indicates presence or absence of P1 phage. 
 
Although Sm-D phenotype was not rescued as indicated by the absence of 
colonies on the Tet only plates, it was of interest to screen available transductants 
for Sm-I or pseudo-dependence. A number of randomly selected colonies of 
YB101(6) and YB101(9) transductants from the Sm/Tet plate were patched on 
LA-N supplemented with Tet only and LA-N  with Sm/Tet.  
 
Table 7. Patching of selected YB101(6) and YB101(9) transductants 
Number of patches showing growth 
on LA-N supplemented with 
antibiotic (g/ml): 
Sm-D mutant 
with Tn10 near 
rpsL 
Tet50 Tet50/Sm200 
co-transduction 
of Tn10 and Sm-
D conferring 
mutation(s) 
YB101(6) 90* 96 94% 
YB101(9) 75* 99 76% 
 
* Patches on tetracycline only plate showed considerably less growth (rated +) as 
compared to patches from the tetracycline and streptomycin plate (rated +++). 
 
Transduction experiments suggested that YB101 derived Sm-D mutants indeed 
carried a mutation in ribosomal protein S12 that conferred a degree of 
streptomycin dependence. However, one could not rule out the possibility that 
more than one genetic locus was responsible for the observed phenotype. 
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3.4 Testing of transformability of Sm-D or Sm-R phenotype of YB101 
mutants in the 7 E. coli strain containing the rRNA plasmid pTS1192U 
 
To settle the question, whether any YB101 derived Sm-D mutants carried an 
rRNA mutation responsible for the observed phenotype, plasmid DNA from 
mutants was used to transform an E. coli lacking in all seven chromosomal rRNA 
operons, and containing an rRNA plasmid pTS1192U. Since the host plasmid has 
a Cm-R marker, one was able to screen on medium containing Amp, in this way, 
selecting for transcription of the mutant plasmid DNA. Competent E. coli host 
strain was prepared as per CaCl2 method and transformed with 10l pool of 
mutant plasmid DNA derived from all of the Sm-D mutants.  Selection was done 
on LA plates supplemented with Amp only, Amp/Sm20 (g/ml) and finally, 
Amp/Sm200 (g/ml).  
 
Table 8. Transformation of 7 E. coli strain with pool of mutant plasmid DNA 
derived from Sm-D mutants 
Number of colonies on LA supplemented with 
antibiotic (g/ml): 
Sample 
Amp200 Amp200/Sm20 Amp200/Sm200 
No DNA control 0 0 0 
Pool of plasmid DNA 34 0 0 
 
 
Transformation results revealed that the neither Sm-R nor Sm-D phenotype was 
transformable with plasmid DNA derived from a pool of Sm-D mutants. Thus, it 
was concluded that the Sm-D phenotype was not due to mutations in the rRNA. 
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3.5 Site directed mutagenesis of pKK3535 
 
As an alternative strategy to obtain an Sm-D mutant in 16S rRNA, site-directed 
mutagenesis was performed on isolated pKK3535 plasmid. This work was 
inspired by the existence of an Sm-D strain isolated from Mycobacterium 
tuberculosis. This strain carries a cytosine insertion mutation in the well 
conserved 530 loop of 16S rRNA which renders it dependent to high levels of Sm 
(more than 50g/ml) (Honore et al., 1995). The existence of an E. coli system 
with a single set of rRNA genes made possible the construction of an analogous 
mutation in the 530 loop of 16S rRNA. To do this, pKK3535 plasmid DNA was 
mutagenized with the aid of a Stratagene QuickChange® II XL Site-Directed 
mutagenesis kit. Mutagenic primers were designed according to Stratagene 
recommendations, with modifications as per Zheng et al (2004).  
 
Table 9.  Mutagenic primers used in the construction of a 16S rRNA mutant 
Primer (5’-3’) Tm (°C) %GC 
530Smd_Frwd: ccgtgcca gccagccgcgg taatacggag 83.05 68 
530Smd_Reverse: ccgcggctggc tggcacgg agttagcc 83.17 74 
 
The site of cytosine insertion is highlighted in red.  
Tm was calculated as per formula supplied with the Stratagene mutagenesis kit. 
Primer-primer melting temperature was 75.2 °C. 
 
Amplification was carried out in a PC-960G Gradient Thermal Cycler. The 
reaction parameters were according to Stratagene specifications with extension 
time of 30 minutes. 5l of the reaction product was used to transform XL10-
Gold® highly competent cells. Selection was done on LA plates supplemented 
with Amp. After overnight incubation, 12 colonies were present. Plasmid DNA 
was extracted from 3 randomly selected colonies and used to transform 7 E. coli 
strain D7. Transformation was done in duplicate, with selection on LA 
supplemented with Amp only and Amp/Sm50 (g/ml).   
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Table 10. Transformation of D7 with site-directed mutagenized pKK3535 
Number of colonies on LA supplemented with 
antibiotic (g/ml): 
Mutagenized pKK3535 
plasmid 
Amp200 Amp200/Sm50 
Sample 1 3 0 
Sample 2 1 0 
Sample 3 4 0 
 
Incubation of LA plates was done for 36 hours at 37ºC. All colonies on Amp 
containing plate were severely retarded in growth. 
 
 
Colonies were patched out on LA supplemented with Amp only and Amp/Sm50 
(g/ml). Following incubation at 37ºC for 18 hours, no growth was observed on 
the Sm containing plate. This suggested that the mutagenized construct failed to 
produce the desired phenotype in the recipient D7 strain. This was either due to 
unsuccessful mutagenesis (which could be verified by sequencing), or the 
insertion of cytosine in the 530 loop of 16S rRNA does not produce the analogous 
Sm-D phenotype seen in M. tuberculosis.  
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3.6 Selection of Sm-D mutants of NF915/ NF916 
 
Following EMS mutagenesis E. coli cultures NF915 and NF916 were serially 
diluted 10-1; 10-2; 10-3 and 10-4 and spread on an LA-N plates. Thereafter, an 
underlay technique was employed with Sm.  
 
Table 11. Dilution series of mutagenized NF915 and NF916 strains on Sm 
containing LA-N plates 
LA-N under-laid with Sm200 (g/ml) 
Number of colonies at dilution: 
 
E. coli strain 
10-1 10-2 10-3 10-4 
NF915 103 6 0 0 
NF916 19 2 0 0 
 
 
95 colonies were selected from 10-1 and 10-2 dilution plates for both NF915 and 
NF916 and patched on LA-N only and LA-N supplemented with Sm.  After 
overnight incubation at 37°C, out of 95 colonies, 9 displayed a distinct Sm-R 
phenotype, while the rest were either true Sm-D or pseudo-dependent mutants 
(frequency ~90%). 
 
6 dependent mutants were chosen randomly, 3 from NF915 and 3 from NF916 
parental strains and a spot test performed to detect the lower limit of Sm-D for the 
selected mutants on varying amounts of Sm containing LA-N plates. An Sm-R 
control was also included. 
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Table 12.  Spot test to detect lower limit of streptomycin dependence in selected 
Sm-D mutants* 
LA-N supplanted with antibiotic (g/ml): Sm-D 
mutants Sm0 Sm5 Sm10 Sm20 Sm40 Sm80 
NF915(a)# +++ +++ +++ +++ +++ +++ 
Sm-D2 - - -+ ++ ++ +++ 
Sm-D3 -(2°) ++ ++ ++ ++ +++ 
Sm-D4 - -(2°) -(2°) ++ ++ +++ 
Sm-D5 - - -(2°) -(2°) -+ ++ 
Sm-D6 - - - -(2°) -+ ++ 
Sm-D7 - - -(2°) ++ ++ +++ 
 
*  each spot was tested in duplicate, the same phenotype was observed. 
#  Sm-R control strain derived from NF915 parental strain. 
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Figure 7. Histogram showing selected Sm-D mutants and their lower limits of 
dependence at various concentrations of streptomycin. 
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3.7 Selection of suppressor mutations near the prfB locus in selected Sm-D 
mutants 
 
In order to detect suppressor mutations in the Release Factor 2 (RF-2), the 
following strategy was developed. An E. coli strain KO1418 containing a Tn10 
marker near the prfB region was a donor for P1 transduction of selected Sm-D 
mutants derived from NF915 and NF916 parental strains. Transductants were 
selected on LA-N supplemented with Sm/Tet. It was of interest to identify those 
transductants that carried the Tn10 marker near prfB and still retained the original 
Sm-D phenotype in each case. To verify this, a spot test was carried out with a 
number of transductants for each Sm-D mutant on increasing concentrations of 
Sm. The original Sm-D mutant was included in each case to serve as a standard 
control against which the Tn10 carrying clones would be compared. Tn10 
carrying clones that most closely matched the original Sm-D phenotype were 
selected for reversion experiments. 
 
Stationary phase cultures of Sm-D mutants with Tn10 marker near prfB were 
plated on LA-N plates supplemented with Tet. Spontaneous Sm-I (reversion) 
mutants were pooled (from plates containing more than a 100 colonies) and used 
as donors for P1 transduction of corresponding original Sm-D mutants. In this 
way, a marker rescue experiment, whereby simultaneous selection for Tet-R 
(Tn10) and Sm-I, was done to detect suppressor mutations near prfB. For this 
purpose, only mutants Sm-D2, Sm-D3 and Sm-D4 were useful. This is because 
the NF916 derived Sm-D mutants failed to produce a reasonable number of 
revertants even when large volumes of stationary phase cultures were used (up to 
200l). Transductants were selected on LA-N supplemented with Tet only and 
LA-N supplemented with Tet/Sm. 
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Table 13. Transduction of Sm-D mutants with phage from corresponding Sm-I 
revertant donors 
Number of colonies on LA-N supplemented with 
antibiotic (g/ml): 
Sm-D mutant 
transduced with 
phage: Tet50/Sm200 Tet50 
Sm-D2 -  0 0 
Sm-D2 +  61 0 
Sm-D3 -  0 0 
Sm-D3 +  33 0 
Sm-D4 -  0 0 
Sm-D4 +  22 0 
 
 indicates P1 phage derived from corresponding Sm-I donors for each Sm-D 
mutant. 
 
Due to the absence of any colonies on LA-N Tet plates, in all cases, it was 
concluded that no suppressor mutations were present near the prfB locus. This 
experiment was repeated with varied amounts of phage and cells, in each case the 
same result was observed.  
 
 
3.8 Selection of suppressor mutations near the rpoB locus in selected Sm-D 
mutants 
 
The initial strategy for obtaining reversion mutations near rpoB of NF915 and 
NF916 derived Sm-D mutants was similar to the above. However, in the course of 
transducing Sm-D mutants with P1 phage derived from an E. coli strain 
CAG18500-Rif-R carrying a Tn10 marker near rpoB, it was noted that in the case 
of Sm-D3, two distinct phenotypic classes of Sm-D clones were obtained when 
tested on increasing concentrations of Sm containing LA-N plates. This was not 
seen with any of the other NF915 or NF916 derived Sm-D mutants.  
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Table 14. Spot-test to determine Sm-D phenotype of Sm-D3 clones with a Tn10 
marker near rpoB 
LA-N supplemented with antibiotic (g/ml): Spot 
Sm0 Sm5 Sm10 Sm20 Sm40 Sm80 Sm160 Sm200/
Rif200 
Sm-D3* - + + ++ ++ ++ +++ - 
Sm-D3* - + + ++ ++ ++ +++ - 
Sm-D3* - + + ++ ++ ++ +++ - 
Sm-D3* - + + ++ ++ ++ +++ - 
1 - -(2°) -(2°) -+ ++ ++ +++ ++ 
2 - + + ++ ++ ++ +++ - 
3 - -(2°) -(2°) -+ + ++ +++ ++ 
4 - -(2°) -(2°) -+ ++ ++ +++ ++ 
5 - -(2°) -(2°) -+ ++ ++ +++ ++ 
6 - -(2°) -(2°) -+ ++ ++ +++ ++ 
7 - -(2°) -(2°) -+ + ++ +++ ++ 
8 - -(2°) -(2°) -+ ++ ++ +++ ++ 
9 - -(2°) -(2°) -+ ++ ++ +++ ++ 
10 - -(2°) -(2°) -+ + ++ +++ ++ 
11 - -(2°) -(2°) -+ ++ ++ +++ ++ 
12 - - -(2°) -+ + ++ +++ ++ 
13 - -(2°) -(2°) -+ ++ ++ +++ - 
14 - -(2°) -(2°) -+ ++ ++ +++ ++ 
15 - -(2°) -(2°) -+ + ++ +++ ++ 
16 - -(2°) -(2°) -+ ++ ++ +++ ++ 
 
*  indicates original Sm-D3 mutant. 
Spots 1 to 16 are Sm-D3 clones transduced with 18500rifR. 
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Table 14 indicates that there were at least two phenotypic classes of Sm-D3 clones 
with a Tn10 marker near rpoB. One class had a minimum requirement of Sm 5 
(g/ml) (as is seen with the original Sm-D3 mutant). The second class was evident 
when the rpoB locus was replaced with that derived from CAG18500 Rif-R strain. 
This class exhibited a higher dependence for Sm 40 (g/ml). It was hypothesized 
that Sm-D mutant Sm-D3 carries two functional mutations with respect to 
streptomycin dependence, one conferred classical dependence, the other near the 
rpoB, conferred a suppression of dependence. It was of interest to determine the 
co-transduction frequencies of Tn10, Rif-R and the dependence suppression (Sm-
Sup) loci. To do this, Sm-D3 was transduced with P1 phage derived from 18500 
Rif-R strain. Transductants were patched on LA-N supplemented with Tet/Sm5 
(g/ml); LA-N supplemented Sm40 (g/ml); and LA-N supplemented with 
Sm200/Rif200 (g/ml).  
 
Table 15. Co-transduction frequencies of Tn10, Rif-R and Sm-Sup in Sm-D3 
LA-N supplemented with antibiotic (g/ml): Sm-D3 transduced 
with 18500rifR Sm40/ Tet30 Sm5/ Tet30 Sm200/ Rif200 
Number of patches 
showing growth 
108 38* 80 
Relevant markers 
tested 
Tn10 Sm-Sup Rif-R 
% co-transduction of 
markers with Tn10 
 64 74 
 
* 10 of 38 patches from Sm5/Tet30 plate were Rif-R.  
% co-transduction was calculated as follows: number of total transductants – 
number colonies present on the selected marker plate / total number of 
transductants X 100. 
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thiC::Tn10 rpoB::Rif-R 
74% 
64% 
Sm-Sup 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. P1 linkage map of the markers thiC::Tn10, rpoB::Rif-R and Sm-Sup 
based on co-transduction frequencies in Table 15. The degree of linkage between 
the markers Rif-R and Sm-Sup indicated that this order of genes was most likely. 
Map units are given in % co-transduction.  
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3.9 Identifying if the LL103 streptomycin dependence inhibition phenotype is 
active in Sm-D3 
 
E. coli mutant LL103 has been previously characterized (Nomura et al., 2003) and 
shown to have a Sm-D suppression mutation in the L7/L12 ribosomal protein. It 
was of interest to examine whether this suppression would also be active in the 
Sm-D3 mutant. A marker rescue strategy was employed. LL103 was made 
resistant to Rif by plating stationary phase culture on Rif containing LA-N plates. 
A single Rif-R mutant was selected and used for transduction with 18500. 
Transductants were selected on Tet. This was done to introduce the Tn10 into a 
region near rpoB.  In order to ensure that the suppression mutation in L7/L12 was 
not replaced, LL103 was first made resistant to Rif before introducing the Tn10. 
Since the map order of markers was thiC::Tn10, rpoB::Rif-R, and L7/L12, it was 
reasoned that the L7/L12 mutation would not be replaced when selecting for a 
clone that was both Tet-R and Rif-R.  
 
Transductants were patched on LA-N supplemented with Tet only and LA-N 
supplemented with Tet/Rif. Result of patching indicated that there was ~84% 
linkage of Tn10 and Rif-R loci in LL103. A single LL103 clone was selected that 
was both Rif-R and had a Tn10 near rpoB region (Tet-R). This clone was a donor 
for P1 transduction of Sm-D3. Transductants were selected on Tet/Sm containing 
LA-N plates. 
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Table 16. Spot-test to determine phenotype of Sm-D3 transduced with 103rifR 
LA-N supplemented with antibiotic (g/ml): Spot 
Sm0 Sm5 Sm10 Sm20 Sm40 Sm80 Sm160 Sm200/Rif 
200 
Sm-
D3* 
- ++ ++ +++ +++ +++ +++ - 
Sm-
D3* 
- ++ ++ +++ +++ +++ +++ - 
Sm-
D3* 
- ++ ++ +++ +++ +++ +++ - 
Sm-
D3* 
- ++ ++ +++ +++ +++ +++ - 
1 - --+ -+ +++ +++ +++ +++ +++ 
2 - --+ -+ +++ +++ +++ +++ +++ 
3 - --+ + +++ +++ +++ +++ +++ 
4 - --+ + ++ +++ +++ +++ +++ 
5 - ++ ++ +++ +++ +++ +++ - 
6 - --+ -+ +++ +++ +++ +++ +++ 
7 - --+ ++ +++ +++ +++ +++ +++ 
8 - ++ ++ +++ +++ +++ +++ - 
9 - --+ -+ ++ +++ +++ +++ +++ 
10 - --+ -+ ++ +++ +++ +++ +++ 
11 - + ++ +++ +++ +++ +++ +++ 
12 - + ++ +++ +++ +++ +++ +++ 
13 - --+ -+ ++ +++ +++ +++ +++ 
 
* indicates original Sm-D mutant. 
 
It was concluded that the streptomycin dependence suppression phenotype of 
LL103 was not expressed in Sm-D3.  
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3.10 Complementation of Sm-Sup mutation in Sm-D3 
 
The initial strategy for complementation of Sm-Sup in Sm-D3 was as follows: 
transducing rifd18 phage (Kirschbaum and Konrad, 1973) derived from an E. coli 
strain NF910 carries genes located at ~88 minutes on the E. coli chromosome. 
This chromosomal region includes genes coding for ribosomal RNA, subunits  
and ’ of RNA polymerase as well as a number of ribosomal proteins (Lindahl et 
al., 1977). Based on linkage information the Sm-Sup mutation is located in the 
chromosomal region described above. Thus, rifd18 is able to complement this 
mutation. For such purpose it was of interest to construct a plasmid vector that 
carries selected ribosomal protein genes derived from rifd18 transducing phage 
DNA. This construct was used for complementation studies. In addition, a low 
copy number vector was needed since over-expression of ribosomal proteins has 
been shown to be moderately toxic to the cell (Fredrick et al., 2000). It was 
decided to use a low copy number vector pACYC184 (see Appendix D). In order 
to complement any mutations within ribosomal protein L7/L12, a vector construct 
needed to carry genes rplL as well as the upstream rplJ coding for ribosomal 
protein L10. This is because L7/L12 is co-transcribed from a common promoter 
located upstream of rplJ (Little et al., 1981). Based on sequence information of E. 
coli K-12, it was decided to use a combination of restriction enzymes of NcoI and 
RcaI to subclone a region of DNA derived from rifd18 into a unique NcoI 
restriction site in pACYC184. The combination of these enzymes would produce 
a 2.1kb DNA fragment carrying the genes rplL, rplJ as well as any upstream 
promoter sequences required for co-transcription of this gene cluster. Upon large 
scale isolation of rifd18 DNA derived from an E. coli strain NF910, restriction 
digests were performed with the above restriction endonucleases. 
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Figure 9. 0.8% agarose gel showing double digestions of rifd18 and cI857 DNA 
with NcoI and RcaI. Arrow points to expected band of ~2.0kb in size. This band 
was not present in wild type cI857 DNA. 
 
 
    
  
Figure 10. 0.8 % agarose gel showing phenol-chloroform extracted 2.0kb DNA 
fragment from low gelling agarose. 
 
 
The selected 2.0kb DNA fragment derived from rifd18 and expected to carry the 
desired gene cluster was sub-cloned into a unique NcoI restriction site located 
within the Cm-R marker on pACYC184. NcoI and RcaI produce compatible 
sticky ends, thus in addition to an NcoI restriction site, a hybrid restriction site 
NcoI/RcaI was expected to form in the resulting construct. Following digestion, 
AP treatment and ligations, E. coli MM294-4 cells were transformed using CaCl2 
method. Due to a lack of positive selection markers in pACYC184, screening for 
clones carrying inserts was a two step process. First, transformed cells were 
selected for Tet-R. Thereafter, transformants were screened for Cm-S by patching 
on LA-N supplemented with Tet only and LA-N supplemented with Tet/Cm. Of 
54 clones screened, 3 were Cm-S. Plasmid DNA was prepared from these clones 
and digested with NcoI.  
 
 
 
 
Lane 3: cI857 digested with 
NcoI and RcaI 
Lane 2: III molecular marker 
Lane 1: rifd18 digested with 
NcoI and RcaI 
Lane 2: III molecular marker 
Lane 1: extracted 2.0kb 
fragment 
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Figure 11. 0.8% agarose gel showing plasmid DNA from selected Cm-S clones 
digested with NcoI. 
 
 
Upon digestion with NcoI the expected DNA construct should only produce one 
band migrating at 6.3kb. However, in all 3 instances, 2 DNA fragments were 
observed. One corresponded in size to the linearized pACYC184 and the other 
corresponded to the 2.0kb insert. Thus, it was concluded that the cloned insert was 
not one expected to carry the desired gene cluster. This led to the development of 
an alternative strategy to complement the Sm-Sup mutation. 
 
 
3.11 Direct genomic PCR of wild-type rplL 
 
In light of failure of previous efforts to complement the functional Sm-Sup 
mutation in Sm-D3, a novel approach was developed. Here, direct PCR, using 
wild type E. coli genome as the template, was used to amplify and clone the ORF 
of rplL into an appropriate plasmid vector. Several issues had to be considered 
prior to this. Since rplL is not transcribed off its own promoter, the cloned 
fragment had to be cloned into a vector with a suitable promoter such as the lac 
promoter. A high copy number plasmid vector pUC18 was chosen for this 
purpose. In addition, it was desirable to achieve low level expression of L7/L12 
due to its toxicity in E. coli. To surmount this potential problem, the PCR product 
was inserted into the poly-linker of pUC18 such that start codon of rplL 
overlapped a stop codon from a residual lacZ gene. This was expected to provide 
a degree of translational down-regulation (Toivonen et al., 1999).   
Lane 5: undigested plasmid 
Lane 4:  III molecular marker 
Lanes 1-3: plasmid DNA from 
chloramphenicol sensitive 
clones digested with NcoI 
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ATGACCATG..............GGGGATCCATTTTAATGTCTATC 
          M  T  M    (8 aa)    G  D  P  L  * M  S  I 
 
lacZ remnant        rplL 
     
 
 
Figure 12. rplL construct in the poly-linker of pUC18. An engineered stop codon 
is indicated with  *. An overlapping, out of frame rplL start codon is underlined. 
Direction of transcription is shown with arrows. Amino acid residues are in blue 
and red for lacZ remnant and rplL respectively.   
 
 
In order to clone the rplL ORF into the desired orientation and position in pUC18, 
several changes needed to be engineered into PCR oligos for amplification of 
rplL. These included restriction recognition sites for BamHI and HindIII as well 
as an overlapping stop codon.  
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L7/Forward primer  
 
    5’ CAGGATCCATTTTAATGTCTATCAC 3’ 
          
TGATATTCAGGAACAATTTAAATGTCTATCACTAAAGATCAAATCATTGAAGCAGTTGCAGCTATGTCTGTAA
TGGACGTTGTAGAACTGATCTCTGCAATGGAAGAAAAATTCGGTGTTTCCGCTGCTGCTGCTGTAGCTGTAGC
TGCTGGCCCGGTTGAAGCTGCTGAAGAAAAAACTGAATTCGACGTAATTCTGAAAGCTGCTGGCGCTAACAAA
GTTGCTGTTATCAAAGCAGTACGTGGCGCAACTGGCCTGGGTCTGAAAGAAGCTAAAGACCTGGTAGAATCTG
CACCGGCTGCTCTGAAAGAAGGCGTGAGCAAAGACGACGCAGAAGCACTGAAAAAAGCTCTGGAAGAAGCTGG
CGCTGAAGTTGAAGTTAAATAAGCCAACCCTTCCGGTTGCAGCCTGAGAAAT 
                     
              3’ TTATTCGGTTCGAAAGGCCA 5’             
 
L7/Reverse primer         
 
Figure 13.  rplL wild type sequence and PCR oligos used for amplification. 
Changes engineered into oligo primers are indicated in blue. Underlined 
sequences are recognition sites for restriction endonucleases, BamHI in 
L7/Forward primer and HindIII L7/Reverse primer. Start and stop codons of the 
rplL ORF are shown in red. Complementary alignment between oligos and rplL 
sequences are indicated with solid lines. 
 
 
Direct colony PCR was performed with the designed oligo primers. E. coli NF915 
was used as the source of wild type ribosomes. A PCR product of 395bp in length 
was expected. 
 
                                                   
                                                                                                                
Figure 14. 1.0% agarose gel showing PCR product. Arrow indicates PCR product 
corresponding to ~400bp in length. Lanes 1 to 3 are standard PCR reaction 
mixtures with increasing concentration of MgCl2 from 2.0mM to 2.8mM. 
 
 
Lane 4: 100bp ladder DNA 
marker 
Lane 1-3: PCR product 
 61 
PCR product was phenol-chloroform extracted directly from PCR mixture and 
double digested with BamHI and HindIII overnight. pUC18 plasmid vector was 
digested with the same restriction endonucleases and treated with AP overnight in 
the appropriate buffer. Phenol-chloroform extraction was then repeated for both 
the PCR product and pUC18 to prepare DNA for T4 ligation. 
 
 
                                                
 
Figure 15. 1.0% agarose gel showing extracted PCR product and pUC18 DNA 
after BamHI and HindIII double digestions. 
 
 
PCR product and pUC18 DNA was ligated with T4 DNA ligase overnight. 
Ligations were used for transformation of competent E. coli XL-1 Blue cells. 
Selection for transformed cells was done on LA supplemented with Amp.  
 
Table 17. Transformation of E. coli XL-1 Blue with DNA ligations 
Ligation mixture Number of colonies on LA 
supplemented with Amp200/Nal 50 
(g/ml): 
No DNA control 0 
pUC18 only 3 
pUC18 and PCR product 41 
 
 
5 randomly selected colonies were picked off the pUC18 and PCR product plate 
and used for small scale plasmid DNA preparation. Aliquots were double digested 
with BamHI and HindIII overnight to confirm the presence of desired insert.  
Lane 3: PCR product DNA 
 
Lane 2: III molecular 
marker 
 
Lane 1: pUC18 DNA 
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Figure 16. 1.0% agarose gel showing BamHI and HindIII double digested DNA 
from selected clones. Arrow points to inserts of ~400bp in length released upon 
double digestions with BamHI and HindIII from clones 1, 3, 4 and 5.  
 
 
pUC18-L12 constructs 1, 4 and 5 were subsequently used to transform competent 
Sm-D3 cells using the CaCl2 method. Transformants were selected on LA-N 
plates supplemented with Amp/Sm. pUC18 and no DNA controls were also 
included. In each case, more than a 1000 colonies appeared on each selection plate 
except for the no DNA control. 4 colonies were picked at random from each plate, 
including the pUC18 positive control and used for a spot-test to determine the 
Sm-D phenotype. 
 
 
 
 
 
 
 
 
 
 
Lane 7: III molecular 
marker 
Lane 6: clone 5 
 
Lane 5: clone 4 
 
Lane 4: clone 3 
 
Lane 3: clone 2 
 
Lane 2: clone 1 
 
Lane 1: pUC18 
digested with BamHI 
and HindIII 
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1. LA-N Amp200/ Sm5   2. LA-N Amp200/ Sm40 
     
 
Figure 17. Spot-test to determine Sm-D phenotype of Sm-D3 transformed with 
constructs pUC18–L12 (1, 4 and 5). Spots are numbered from left to right. Spots 
1, 5, 9, 13 are Sm-D3 clones transformed with pUC18 controls. Spots 2, 6, 10, 14 
are Sm-D3 clones transformed with construct pUC18-L12(5). Spots 3, 7, 11, 15 
are Sm-D3 clones transformed with pUC18-L12(4). Spots 4, 8, 12, 16 are Sm-D3 
clones transformed with pUC18-L12(1).  The spot-test was done in duplicate with 
and without the addition of 1.0mM IPTG, this had no effect on the observed 
phenotype. No growth was observed for any spots on the LA-N supplemented 
with Amp only plate (not shown). 
 
 
Figure 17 indicates that two Sm-D3 clones, one carrying pUC18-L12(5) and the 
other, pUC18-L12(1) exhibited reduced growth on low concentration of Sm5 
(g/ml). It can be concluded that the construct pUC18-L12 was successful in 
complementing the Sm-Sup mutation. Thus, this mutation was placed within the 
rplL ORF. However, since not all transformed clones showed this phenotype, it 
was hypothesized that complementation was due to homologous recombination 
and not expression of the L7/L12 protein from the construct.  
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3.12 Testing level of expression of -galactosidase system in the Sm-D3 
mutant background 
 
The available -galactosidase reporter system is used as a measure of levels of 
gene expression. In addition it has been demonstrated that certain codons at 
position +2 downstream of the start codon have low efficiencies with regard to 
translation initiation (Stenström et al., 2001). Using constructs developed by 
Stenström, (see Appendix E) it was possible to assay -galactosidase expression 
efficiency in an Sm-D background.  
 
Sm-D3 was transformed with a number of constructs corresponding to high and 
low efficiency codons at +2 position using the CaCl2 method. Selection was 
carried out on LA supplemented with Amp/Sm. Single colonies were used to start 
cultures for the subsequent assay.  
 
Table 18. The effect of selected +2 codons on translational efficiency in Sm-D3 
as compared to wild-type background 
Relative expression of codons tested at position +2 Background 
AAA AGA AGG CGA CGC CGG CGU 
w.t. 1.0 0.67 0.11 0.27 0.22 0.07 0.32 
Sm-D3 0.51 0.60 0.08 0.12 0.13 0.03 0.17 
 
Assay values are given as relative expression whereby 1.0 is equivalent of 
234±7.6 (X 10-3) -galactosidase units. Each codon was sampled 4 times. The 
values for the wild-type (w.t.) background were as per Stenström et al., (2001). 
 
The generated assay data indicated that the measured level of expression was 
generally lower in Sm-D3 as compared to wild-type. For codons CGA, CGC, 
CGG, CGU and AAA the level of expression was ~2-fold lower. 
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3.13 Testing selected +2 low and high efficiency codons in Sm-D mutants 
derived from NF915 and NF916 strains 
 
Sm-D mutants derived from NF915 and NF916 parental strains were assayed 
using the -galactosidase reporter system. Assayed codons were restricted to a 
high efficiency AAA (coding for lysine) and a low efficiency CGG (coding for 
arginine). Sm-D mutants 2, 4, 5, 6 and 7 were transformed with selected -
galactosidase reporter system constructs. Selection was done on LA plates 
supplemented with Amp/Sm. 
 
Table 19. Expression of high and low efficiency codons in Sm-D mutants derived 
from NF915 and NF916 
Relative expression of codons tested at position +2 Background 
AAA CGG 
w.t. 1.0 0.07 
Sm-D2 0.56 0.06 
Sm-D4 0.53 0.05 
Sm-D5 0.29 0.04 
Sm-D6 0.42 0.04 
Sm-D7 0.47 0.02 
 
Each codon was sampled 4 times. The values for the wild-type (w.t.) background 
were as per Stenström et al., (2001). 
 
 
Based on experimental evidence, it was concluded that all Sm-D mutants assayed 
exhibited a reduced level of expression regardless of the codon type tested at 
position +2 as compared to wild-type. This is in agreement with the previously 
observed decreased efficiency of translation associated with hyper-accuracy 
(Ruusala et al., 1984).  
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4. Discussion 
 
4.1 Isolation of Sm-D mutants in rRNA 
 
With the recent development of an E. coli system that has a single rRNA operon 
located on a plasmid (Asai et al., 1999), a vast gap in the understanding of the 
function of ribosomal RNA can be overcome. Previous efforts to characterize the 
structure-function relationships in rRNA have been based on visualization 
techniques. However, such an approach has limitations when one wishes to 
consider a closer picture of specific interactions within, and between ribosomal 
components. In addition, the contribution of research into antibiotics that target 
bacterial ribosomes has been very fruitful for furthering the understanding 
functional interactions in the ribosome. Thus it became possible, for the first time, 
to generate mutations in rRNA that confer antibiotic resistance or dependence in 
E. coli, and to characterize these mutations with respect to second site 
suppressors. Of particular interest was the development of antibiotic dependent 
mutants. This is because the isolation of second site suppressor mutations would 
be a technically simple procedure of direct selection.  
 
In light of the above, a strategy was developed for the generation of Sm-D 
mutants in ribosomal RNA of E. coli. This involved the use of the previously 
described SQ170 strain deficient in all seven chromosomal rRNA operons. 
Mutants of this strain would be generated by high throughput chemical 
mutagenesis, and selected directly for the desired phenotype of streptomycin 
dependence. Furthermore, it was hypothetically possible to select for rRNA 
mutants by re-transformation of mutated plasmids into the original host strain, 
since only one plasmid-borne rRNA operon was present in this background.  
 
Before the implementation of this strategy, it became immediately apparent that 
the presence of a Sp-R determinant in the SQ170 strain could affect further work 
with Sm since both of these antibiotics belong to the aminoglycosidic group. That 
is, one needed to avoid possible cross-reactivity with respect to antibiotic 
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resistance. To this extent, NTG mutagenesis was preformed to select for Sp-S 
clones. In retrospect this was not the ideal means of eliminating the Sp-R marker 
since this particular form of chemical mutagenesis is severely destructive. In 
addition, mutations generated by this method are localized to the DNA replication 
fork (Isaksson personal communication), thus a heterogeneous pool of plasmids 
would be generated in each clone. Despite of this, a number of candidate Sp-S 
clones were identified through counter-selection. The clone that showed the 
cleanest phenotype with respect to reversion and streptomycin cross-reactivity 
was selected and termed YB101.  
 
This clone was subsequently subjected to a second round of chemical mutagenesis 
to select for Sm-D mutants. EMS was employed for this purpose. The rational for 
using this agent was the fact that predominantly transition type mutations are 
obtained. The reasoning was that subtle mutations in rRNA are required to 
achieve the desired phenotype. A large number of Sm-D mutants were generated 
in this manner. To distinguish between classical ribosomal protein mutants that 
give rise to streptomycin dependence (S12), and those that were plasmid-borne, an 
obvious screening involving re-transformation of isolated mutant plasmid DNA 
into the original host strain followed. Despite the recurrent problems of low 
transformation efficacy, it became clear that none of the isolated Sm-D clones 
from the SQ170 parental strain gave rise to a selectable Sm-D phenotype upon re-
transformation. 
 
Several testable hypotheses were put forward to explain the lack of 
transformability of the Sm-D phenotype. Initially, it was thought that direct 
selection of streptomycin dependence would be possible. In this scenario, one was 
able to simultaneously select for Amp and Sm, driving the selection of 
transcription in favor of the incoming plasmid in the host strain. Thus, it was 
assumed that the lack of transformability of Sm-D from incoming mutated 
plasmids reflects the fact that none of the obtained Sm-D mutants carried a 
plasmid-borne mutation. Alternatively, and perhaps unlikely, all of the Sm-D 
mutants carried at least two mutations responsible for the observed phenotype. 
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One chromosomal (presumably S12) and a second, in the plasmid encoded rRNA. 
This hypothesis was tested by a marker rescue experiment whereby the host rplL 
was replaced with a wild-type through P1 mediated transduction. The results seem 
to indicate that the tested Sm-D strains indeed carry chromosomal Sm-D or Sm-R 
mutation. The distinction between these two was unclear since direct marker 
rescue was not successful (on Tet only). Co-transduction frequencies were 
determined by patching out colonies from the plate containing both Tet and Sm, 
suggesting that these clones were still Sm-D. However, patching revealed that 
more than 76% of transductants were able to grow on Tet only (although 
considerably slower). Thus, the question of plasmid-borne Sm-D or Sm-R 
transformability was still unresolved.  
 
To shed light on the seemingly ambiguous result obtained with marker rescue 
experiments, it was desirable to transform mutant plasmids obtained from selected 
SQ170 derived Sm-D mutants into a host strain with a different selectable marker. 
This became available in the form of D7, a strain derived from SQ170 but 
harboring a chloramphenicol determinant on the rRNA plasmid (pTS1192U). 
Literature indicates that when transforming mutated plasmids into the original 
host strain, a selection condition has to be in favor of the incoming plasmid in 
order to displace the resident plasmid (Vila-Sanjurjo and Dahlberg, 2001). Thus, it 
was possible to select simultaneously for Amp and Sm, in hope that this will drive 
the selection of transcription for the incoming plasmid and displace the resident 
one.  
 
The results of this experiment showed that, in addition to the previously 
encountered problem of low transformation efficacy, neither the Sm-D nor the 
Sm-R phenotype were transformable. A conclusion can be drawn from this. Either 
there was a failure to obtain any type of functional Sm-D mutants within rRNA, 
or there is an inherit problem of selection of such plasmid-borne mutants in a new 
host. A possible reason for this has been addressed by Vila-Sanjurjo et al., (1999). 
It was noted that when an incoming plasmid rendered the ribosomes non-
functional, the incoming and the resident plasmids would coexist in the same 
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cells. A similar condition could have arisen in the above case. Here, the incoming 
plasmid carrying an Sm-D mutation would not be able to displace the resident 
wild type due to the decreased selection pressure associated with the reduced 
growth rate of a severely restrictive hyper-accurate phenotype. This would result 
in a heterogeneous population of ribosomes in the host.  
 
Interestingly, it has been reported by Frattali et al., (1990) that a 16S rRNA 
mutation U912 can result in a low level Sm-R phenotype, but only with serial sub-
culturing on increasing levels of Sm. Despite the fact that these experiments were 
done in MM294 (which has all seven chromosomal rRNA operons) a parallel 
could be drawn with respect to the above. Such sub-culturing could progressively 
select for the incoming plasmid while retarding transcription of the resident 
rRNA. In light of this, it would be of interest to further examine and characterize 
YB102 transformants carrying mutant plasmid DNA from YB101(6), YB101(9) 
and YB101(pool). Serial sub-culturing of these clones on Amp/Sm could drive 
selection in favor of the incoming plasmids.  
 
To give further insight into the mechanism of rRNA encoded Sm-D mutations and 
associated problems of selection, it was decided to construct a mutant pKK3535 
plasmid with a cytosine insertion in the highly conserved 530 stem-loop. Such a 
mutation has been previously characterized and found to be associated with high 
level of streptomycin dependence in M. tuberculosis (Honore et al., 1995). In light 
of the high degree of sequence identity in the 530 loop, it was reasoned that an 
analogous mutation in the E. coli strain with a single rRNA operon would produce 
a similar Sm-D phenotype. Following site-directed mutagenesis, the mutant 
plasmid was transformed into the host D7. Selection for Sm-D or Sm-R failed to 
produce any results. A number of possible reasons exist to explain this; (1), the 
problems associated with displacement of the resident plasmid previously 
discussed could have hindered selection of the desired phenotype; (2), in spite of 
the high degree of conservation within the 530 stem-loop, the described mutation 
in M. tuberculosis may not have the same phenotype in E. coli; (3), least likely, 
there was experimental failure in the mutagenesis of pKK3535, thus the tested 
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clones were simply wild-type. This could be verified by sequencing. Due to time 
constraints, further work with this mutation was limited.  
 
It can be added that assuming mutagenesis was successful, and the mutant 
plasmid has indeed displaced the resident one, the effects of a cytosine insertion 
should be investigated on a broader scale. This would entail studies with growth 
rates, efficiency of translation and conditional lethality.  
 
Future work with ribosomal RNA mutations associated with antibiotic resistance 
or dependence should primarily focus on the development of a stable system in E. 
coli whereby more than one selectable marker can be employed to displace 
resident plasmids and drive transcription in favor of the incoming one. In addition, 
more than one type mutagenesis should be used when generating plasmid-borne 
rRNA mutants. Alternatives to chemical mutagens could include the use of 
mutator strains. This will provide for an increased diversity of mutation types 
such as insertions and deletions. Finally, one can adopt a different approach to the 
issue of functional interactions between rRNA and ribosomal proteins. Here, a 
pool of mutagenized rRNA plasmids can be used to rescue conditional lethal 
mutants harboring known mutations in ribosomal proteins. This methodology can 
potentially bypass plasmid displacement problems.  
 
 
4.2 Isolation and characterization of Sm-D mutants derived from E. coli 
strains NF915 and NF916 
 
The classical investigation of ribosomal protein mutants and related antibiotic 
resistances has yielded a great deal of insight into the various functional 
interactions in the ribosome. This approach is technically accessible and well 
documented.  
 
A number of Sm-D mutants were derived from E. coli strains NF915 and NF916 
through chemical mutagenesis and direct selection. Mutants that were useful for 
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further work were selected based on phenotypic differences such as colony 
morphology and level of dependence to Sm. It was assumed that any Sm-D 
phenotype was the result of mutations in S12. Of interest was to get second site 
suppressor mutations that completely reversed Sm-D to Sm-I. The initial strategy 
to obtain second site suppressors involved a simple marker rescue experiment 
whereby Sm-D mutants carrying a Tn10 near a locus of interest were selected for 
independence to Sm. Revertants were used in P1 mediated transduction 
experiments to rescue Sm-D mutants with simultaneous selection on Tet. In this 
way, a number of loci were tested. 
 
The first subject of interest was the locus prfB coding for RF-2. Cryo-electron 
microscopy indicates that the RF-2 termination complex interacts directly with the 
decoding center on the ribosome. Contacts include helix 18 and 44 of 16S rRNA 
as well as S12 (Klaholz et al., 2003). Additionally, another protein factor, EF-Tu 
has been found to interact with the decoding center and reverse streptomycin 
dependence (Zuurmond et al., 1998). Based on this, it was reasoned that such 
close association with the decoding center could have implications on the binding 
of streptomycin to Sm-D ribosomes. Sm-D mutants derived from NF915 were 
screened in the manner described above for second site suppressor mutations near 
the prfB locus. It is worth noting that Sm-D mutants derived from NF916 were 
less amendable to Sm-D reversion when selected for Sm-I. This could be a 
function of the genetic difference between NF915 and NF916. 
 
Results of screening experiments suggested that no second site suppressors were 
present near prfB. A number of possibilities exist to explain this. First, even 
though the technical approach was sound, simply not enough spontaneous 
revertants were pooled. This can be considered if the frequency of hypothetical 
second site suppressors of Sm-D in RF-2 is extremely low. Second, literature 
indicated that S12 mutations that result in Sm-D phenotype are hyper-accurate, 
compensating for the error-prone effects of streptomycin. In addition, second site 
suppressors that result in Sm-I are typically involved in tRNA selection and 
proofreading associated with 912 region of 16S rRNA (Lodmell and Dahlberg, 
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1997). It can be argued that since RF-2 does not directly affect tRNA selection 
during initial proof-reading, but has direct contacts to S12, the only likely 
mechanism of Sm-D suppression would be distortion of S12. Such distortion 
might not be accessible to RF-2 since this requires specific interactions. 
 
To resolve this matter, one can consider a more direct approach of selective 
mutagenesis of prfB through site-directed mutagenesis or gene replacement (Zeef 
and Bosch, 1993). In this way, RF-2 mutants can be preferentially selected and 
screened using previously described techniques. Interestingly it has been found 
that Sm-D5 mutant exhibited a decreased requirement for Sm when rescued by a 
Tn10 near prfA (Dabbs personal communication). This might reflect the 
possibility of isolating RF mutants in E. coli that can reverse the Sm-D phenotype. 
 
The second genetic locus of interest examined for possible second site suppressor 
mutations was rpoB. This region was of particular interest since several large 
ribosomal subunit proteins are located in this region. These include L1, L10, L11, 
L7/L12 as well as protein factor EF-Tu. In light of the previously reported 
isolation and characterization of a Sm-D suppressor in L7/L12 (Nomura et al., 
2003), the rpoB gene cluster presented a good starting point for the search of other 
Sm-D suppressors.  
 
To isolate Sm-D suppressors near rpoB, a similar marker rescue methodology was 
employed as described above. Following transduction of Sm-D3 with 
18500rifR, it was noted that two distinct phenotypic classes were present. Thus, 
it appeared that a mutation in the rpoB gene cluster reduced the requirement to 
streptomycin of Sm-D3. The mutation was roughly mapped to be in L7/L12 or 
more distal L10. As a matter of interest, a question was posed whether the 
characterized L7/L12 suppressor of Sm-D from LL103 also was functional in Sm-
D3 background. Although there appeared to be a slight decrease in streptomycin 
requirement, the LL103 derived L7/L12 failed to reverse Sm-D phenotype of Sm-
D3. Whether the observed decrease in dependence was significant, or a result of 
variations in experimental conditions, this was not explored any further.  
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Efforts to fine-map the Sm-Sup mutation near rpoB began by focusing on the 
transducing phage rifd18. Literature indicates that this phage can be usefull in the 
construction of plasmids harboring genes near rpoB (Bernardi and Bernardi, 
1979). However, in the processes of sub-cloning rplL technical difficulties were 
encountered. It was found, through restriction analysis and cloning, that DNA 
isolated from rifd18 was not that expected when compared to previously 
published data. This was probably reflective of the general difficulties in the 
process of isolation of rifd18 from NF910 and subsequent DNA purification from 
this phage (Pica and Calef, 1968; Lindahl et al., 1977).  
 
As a more direct approach, complementation of Sm-Sup was achieved by cloning 
a PCR fragment of wild-type rplL into pUC18 cloning vector. Initially, it was 
desirable to obtain a moderate level of expression from the cloned rplL gene. To 
this extent, several criteria were fulfilled during cloning, including placing an 
overlapping stop codon near the rplL AUG as per Toivonen et al., (1999). 
However, it was noted that not all Sm-D3 clones transformed with the construct 
pUC18-L12 were able to complement the Sm-Sup mutation even under IPTG 
inducing conditions. This was explained as follows: since Sm-D3 is not 
recombination deficient, complementation of Sm-Sup was due to recombination 
of plasmid-borne wild type rplL and the chromosomal mutant, and not due to 
expression of L7/L12 from construct (Faustoferri et al., 1998; Ryden et al., 1986). 
This hypothesis can be tested by constructing a Rec minus derivative of Sm-D3 
through P1 mediated transduction, followed by screening for Sm-Sup 
complementation (Dabbs personal communication). In addition, expression of 
L7/L12 from the pUC18-L12 construct can be monitored with optimized IPTG 
induction conditions on SDS-PAGE gels. 
 
Complementation experiments confirmed the location of Sm-Sup mutation in 
L7/L12. This was not surprising since a number of L7/L12 mutants have been 
isolated that suppress Sm-D phenotypes and the involvement of L7/L12 in 
translational accuracy has been documented (Kirsebom and Isaksson, 1985). This 
is in accordance with the currently accepted model of the role of S12 in the 
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decoding centre of the ribosome. It can be hypothesized that a hyper-accurate 
mutation in S12 resulting in reduced translational efficiency is “balanced out” by 
the presence of a L7/L12 mutation that leads to increased misreading. An 
analogous condition has been identified by Kirsebom and Isaksson, (1985).  
 
Finally, one can speculate that mutations that counteract hyper-accuracy 
associated with Sm-D phenotypes have the selective advantage of increased 
growth rate due to increased translation efficiency.  
 
 
4.3 Testing translation initiation efficiency in Sm-D3 
 
To answer the question, whether Sm-D3 mutant has increased translation 
efficiency due to a compensatory L7/L12 mutation, this mutant was assayed with 
the -galactosidase reporter system using constructs developed by Stenström et 
al., (2001). Since these constructs have a well established expression profile in 
wild-type E. coli, it was possible to compare translation initiation efficiencies in 
the Sm-D3 background. The existence of mRNA codons downstream of the AUG 
that give poor gene expression (Gonzalez de Valdivia and Isaksson, 2004), 
prompted a search for ribosomal mutants that can enhance translation initiation 
efficiencies of these codons. The current hypothesis to explain poor gene 
expression of such codons is associated with peptidyl-tRNA drop-off from the A-
site before translocation due to an increased affinity of tRNA anti-codons at these 
sites (Gonzalez de Valdivia personal communication). This suggests that such 
drop-off occurs after initial tRNA selection and proof-reading mediated by 30S 
domain closure but before translocation. In this case, one would expect to find that 
neither Sm-D hyper-accurate, nor ram error-prone ribosomes affect these codons 
since the drop-off event is downstream of tRNA selection and proofreading.  
 
The result of -galactosidase assay using both high and low efficiency codons 
indicated that there was generally a decreased level of gene expression regardless 
of the type of codon tested. This was true not only for Sm-D3 but also for all 
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NF915 and NF916 derived Sm-D mutants. A number of conclusions can be made: 
(1), observations were in accordance to the well documented decrease in gene 
expression of Sm-D ribosomes associated with hyper-accuracy; (2), the 
hypothesis proposed to explain low efficiency codons associated with peptidyl-
tRNA drop-off is supported by the obtained results since Sm-D ribosomes were 
not expected to affect reactions downstream of 30S subunit closure; (3), it can be 
said that the level of gene expression tested with specific codons downstream of 
AUG in Sm-D3 background was comparable to that observed with other Sm-D 
mutants. This indicates that the L7/L12 Sm-Sup mutation does not play a 
significant role in efficiency of translation in Sm-D3 in relation to other Sm-D 
mutants.  However, in order to say anything about the absolute effect of Sm-Sup 
in Sm-D3, one has to compare both Sm-D3 and Sm-D3 Sm-Sup minus gene 
expression levels. Due to time constraints this was not assayed.  
 
Future studies must deal with sequencing of the Sm-Sup mutation in L7/L12. This 
mutation is of interest since it does not completely reverse Sm-D to Sm-I. 
Importantly, the L7/L12 mutant needs to be characterized biochemically. This 
would shed more light on this flexible ribosomal protein whose precise role is not 
fully understood.  In addition, ribosomal mutants that rescue poor efficiency 
codons should be identified. This would assist the elucidation of the nature of 
poor gene expression associated with certain codons, and have practical 
applications. 
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5. Conclusions 
 
 
In the process of selection of Sm-D mutants in rRNA, it became evident that the 
proposed approach is potentially useful for identifying and characterizing specific 
rRNA loci that have important functions in the ribosome. Additionally a number 
of specific technical issues were identified that can be addressed in future studies. 
 
Classical experiments involving generation of antibiotic resistance mutants in 
ribosomes, and second site suppressors, have confirmed this approach as fruitful 
and instrumental in elucidating the complex structure-function relations in 
ribosomal components.  
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Appendix A: Media and Solutions 
 
Media 
 
LB (Luria Bertani broth) 
 1.0g tryptone 
 0.5g yeast extract 
 0.5g NaCl 
 Distilled water to 100ml 
 
LA (Luria Bertani agar) 
 1.0g tryptone 
 0.5g yeast extract 
 0.5g NaCl 
 1.5g technical agar 
 Distilled water to 100ml 
 
LA (A-N) 
 1g tryptone 
 0.5g yeast extract 
 1.5g technical agar 
 10ml 10 X (A-N) stock 
 Distilled water to 100ml 
 
LC plates  
 As LA + 10mM CaCl2 
 
 
½ Agar (sloppy agar) 
 As LA except 0.75g technical agar 
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10 X A-N buffer 
 91.7g K2HPO4.3H2O 
 26.8g KH2PO4 
 5.0g Na3(citrate) 
 1.0g MgSO4 
Distilled water to 1000ml  
 
Plasmid Preparation Solutions 
 
Solution 1 
 50mM glucose
 
 25mM Tris-HCl pH 8.0 
 10mM EDTA pH 8.0 
 
Solution 2 
 0.2M NaOH 
 1.0% SDS 
 
Solution 3 
 60ml 5M CH3COOK solution 
 11.5ml CH3COOH 
28.5ml distilled water 
pH 4.8 
 
Solutions Used for Agarose Gel Electrophoresis 
  
5 X TBE 
 54.0g Tris base 
 27.5g H3BO3 
 20ml 0.5 EDTA pH 8.0 
 Distilled water to 1000ml 
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Agarose gel stock solutions 
 0.8g, 1.6g or 2.0g agarose 
 20ml 5 X TBE 
Distilled water to 200ml 
 
Running Buffer 
 0.5 X TBE 
 0.1µg/ml EtBr 
 
Molecular Weight Markers 
 5µl molecular weight marker 
 10µl buffer H 
 85µl sterile water  
 20µl tracking dye 
 
E. coli Transformation Solutions 
   
Transformation Buffer 
 100mM CaCl2 
 10mM Tris-HCl pH 7.5 
 
 
 phage preparation solutions 
 
SM buffer 
 100mM NaCl 
 1mM MgSO4 
 
20mM Tris-HCl (pH7.5) 
 0.01% gelatin 
 
 
 
 80 
 dialysis buffer 
 10mM NaCl 
 50mM Tris-HCl (pH 8.0) 
 10mM MgCl2 
 
 
-Galactosidase assay 
 
Z buffer 
Per liter: 
 16.1g Na2HPO47H2O 
 5.5g NaH2PO4H2O 
 0.75g KCl 
 0.246g MgSO47H20 
 2.7ml -mercaptoethanol 
Do not autoclave 
Adjust pH to 7.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 81 
Stock Solutions of Antibiotics 
Antibiotic Concentration Solvent 
Ampicillin 100mg/ml 7:3 ethanol:water 
Chloramphenicol 10mg/ml ethanol 
Nalidixic acid 10mg/ml ethanol 
Rifampicin 10mg/ml methanol 
Spectinomycin 10mg/ml water 
Streptomycin 100mg/ml water 
Tetracycline 10mg/ml methanol 
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Appendix B: restriction map of pKK3535 
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Appendix C: restriction map of pUC18 and multiple cloning site 
(MCS) 
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Appendix D: restriction map of pACYC184 
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Appendix E: restriction map of pCMS71 
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Appendix F: open reading frame (ORF) of rplL 
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Appendix G: Molecular weight DNA markers 
 
 
 
 
 
 
 
                                                             
 
   III molecular marker        GeneRuler 100bp DNA ladder 
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